1. Home
  2. RXT vs ALT Comparison

RXT vs ALT Comparison

Compare RXT & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RXT
  • ALT
  • Stock Information
  • Founded
  • RXT 1998
  • ALT 1997
  • Country
  • RXT United States
  • ALT United States
  • Employees
  • RXT N/A
  • ALT N/A
  • Industry
  • RXT EDP Services
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • RXT Technology
  • ALT Health Care
  • Exchange
  • RXT Nasdaq
  • ALT Nasdaq
  • Market Cap
  • RXT 332.7M
  • ALT 333.6M
  • IPO Year
  • RXT 2020
  • ALT N/A
  • Fundamental
  • Price
  • RXT $1.43
  • ALT $3.95
  • Analyst Decision
  • RXT Hold
  • ALT Strong Buy
  • Analyst Count
  • RXT 5
  • ALT 6
  • Target Price
  • RXT $1.58
  • ALT $17.40
  • AVG Volume (30 Days)
  • RXT 1.1M
  • ALT 2.6M
  • Earning Date
  • RXT 11-11-2025
  • ALT 11-11-2025
  • Dividend Yield
  • RXT N/A
  • ALT N/A
  • EPS Growth
  • RXT N/A
  • ALT N/A
  • EPS
  • RXT N/A
  • ALT N/A
  • Revenue
  • RXT $2,693,100,000.00
  • ALT $20,000.00
  • Revenue This Year
  • RXT N/A
  • ALT N/A
  • Revenue Next Year
  • RXT $1.59
  • ALT N/A
  • P/E Ratio
  • RXT N/A
  • ALT N/A
  • Revenue Growth
  • RXT N/A
  • ALT N/A
  • 52 Week Low
  • RXT $1.00
  • ALT $2.90
  • 52 Week High
  • RXT $3.41
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • RXT 52.95
  • ALT 52.90
  • Support Level
  • RXT $1.34
  • ALT $3.85
  • Resistance Level
  • RXT $1.58
  • ALT $4.06
  • Average True Range (ATR)
  • RXT 0.08
  • ALT 0.23
  • MACD
  • RXT -0.00
  • ALT 0.02
  • Stochastic Oscillator
  • RXT 35.42
  • ALT 51.92

About RXT Rackspace Technology Inc.

Rackspace Technology Inc is an end-to-end, hybrid, multi cloud technology services company. It designs, builds and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services; Data; Colocation; Cloud; Managed Hosting; Professional Services; and Security & Compliance. It operates in segments namely, Private Cloud, and Public Cloud. It generates revenue through the sale of consumption-based contracts for its service offerings and from the sale of professional services related to designing and building custom solutions.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: